FX100 dialyzer
Devicecomparison of dialyzers
Other names: Fresenius FX 100
NCT Number: NCT02546037
Primary Objective:
The purpose of this study is to measure the amount of convection achieved with two different haemodiafilters designed for haemodiafiltration and clotting during haemodiafiltration treatment.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
This is a prospective observational cohort pilot study of patients under the care of the Royal Free Hospital with chronic kidney disease who have been established on regular thrice weekly haemodiafiltration treatments in a dialysis centre. Information on the study will be disseminated to the Royal Free consultant nephrologists at the dialysis centre with primary responsibility for the individual patient.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
comparison of dialyzers
Other names: Fresenius FX 100
comparison of dialyzers
Time frame: day 1
volume of convective exchange achieved during the HDF session
Time frame: day 1
measurement of coagulation pathway proteins and platelet activation markers
Time frame: day 1
visual analogue score assessment of clotting in the extracorporeal circuit
Time frame: day 1
dialyzer clearance of small and middle sized molecules, including urea and beta 2 microglobulin
University College, London
Other
Pilot Study to Determine the Effect of Different Dialyzer Membranes on Clotting During Haemodiafiltration Treatments in Patients With Chronic Kidney Disease
Acronym: TAGPSOLACEA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03418181
Dialysis, Female Urogenital Diseases
Stevenage, United Kingdom
View Trial DetailsNCT07704008
Anxiety Disorders, Female Urogenital Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT01595984
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Amiens, France
View Trial DetailsNCT00213590
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Rouen, France
View Trial Details